Immediate Impact
44 standout
Citing Papers
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
2023 Standout
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
2023 Standout
Works of Andrew Lin being referenced
Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
2020
Multiplexed Microsphere Suspension Array-Based Immunoassays
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Andrew Lin | 79 | 68 | 102 | 120 | 80 | 36 | 386 | |
| Huiying Xu | 12 | 18 | 34 | 34 | 55 | 36 | 337 | |
| Reynolds Hy | 46 | 36 | 56 | 129 | 27 | 15 | 387 | |
| Takayuki Imai | 9 | 23 | 126 | 152 | 28 | 39 | 444 | |
| Imad Bou Akl | 6 | 15 | 99 | 71 | 13 | 34 | 424 | |
| Edwin J. Smith | 15 | 55 | 138 | 141 | 23 | 20 | 442 | |
| Juan Carlos Andreu‐Ballester | 12 | 58 | 45 | 85 | 20 | 33 | 437 | |
| Sabine Pirr | 10 | 12 | 19 | 76 | 15 | 26 | 357 | |
| Aarti Agarwal | 46 | 10 | 20 | 42 | 21 | 38 | 457 | |
| Richard H. Rapkin | 2 | 29 | 174 | 199 | 17 | 26 | 438 | |
| Satoshi Okamori | 6 | 19 | 159 | 230 | 15 | 34 | 442 |
All Works
Login with ORCID to disown or claim papers
Loading papers...